FDA User Fees, Drug Competition and Drug Pricing: Catalyst to Present on Regulatory and Legislative Vehicles for Change

On June 13, Catalyst President Nancy Bradish Myers will present on PDUFA and other user fee agreements, and their impact on drug competition.

Ms. Myers will be a featured speaker for the FDANews webinar, “Impact: FDA User Fees, Drug Competition and Pricing – An Inside View.” She will explore how user fee agreements have driven competition – for branded products, generics and biosimilars – and how Commissioner Scott Gottlieb’s agenda is designed to promote competition.